[Secondary prevention of coronary heart disease. How effective are modern therapy methods?].
Kolenda
K-D
KD
Ostseeklinik Schönberg-Holm, Fachklinik für Rehabilitation, Klinik für Anschlussheilbehandlung und Anschlussrehabilitation, Schönberg. medizin@okli-holm.de
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D015906:Angioplasty, Balloon, Coronary; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D003131:Combined Modality Therapy; D018849:Controlled Clinical Trials as Topic; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000188:drug therapy / Q000517:prevention & control* / Q000601:surgery; D015444:Exercise; D005500:Follow-Up Studies; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D008019:Life Style; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012064:Relaxation Therapy; D012307:Risk Factors; D016540:Smoking Cessation; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D010975:Platelet Aggregation Inhibitors
Sekundärprävention der koronaren Herzkrankheit. Wie wirksam sind die modernen Behandlungsmethoden?